These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Mitochondrial dysfunction and intracellular calcium dysregulation in ALS. Kawamata H; Manfredi G Mech Ageing Dev; 2010; 131(7-8):517-26. PubMed ID: 20493207 [TBL] [Abstract][Full Text] [Related]
23. AMPK Signalling and Defective Energy Metabolism in Amyotrophic Lateral Sclerosis. Perera ND; Turner BJ Neurochem Res; 2016 Mar; 41(3):544-53. PubMed ID: 26202426 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of Drp1/Fis1 interaction slows progression of amyotrophic lateral sclerosis. Joshi AU; Saw NL; Vogel H; Cunnigham AD; Shamloo M; Mochly-Rosen D EMBO Mol Med; 2018 Mar; 10(3):. PubMed ID: 29335339 [TBL] [Abstract][Full Text] [Related]
25. The mitochondrial permeability transition pore in motor neurons: involvement in the pathobiology of ALS mice. Martin LJ; Gertz B; Pan Y; Price AC; Molkentin JD; Chang Q Exp Neurol; 2009 Aug; 218(2):333-46. PubMed ID: 19272377 [TBL] [Abstract][Full Text] [Related]
26. Mitochondria-targeted catalase reverts the neurotoxicity of hSOD1G⁹³A astrocytes without extending the survival of ALS-linked mutant hSOD1 mice. Pehar M; Beeson G; Beeson CC; Johnson JA; Vargas MR PLoS One; 2014; 9(7):e103438. PubMed ID: 25054289 [TBL] [Abstract][Full Text] [Related]
27. Mitochondria: A Promising Convergent Target for the Treatment of Amyotrophic Lateral Sclerosis. Cunha-Oliveira T; Montezinho L; Simões RF; Carvalho M; Ferreiro E; Silva FSG Cells; 2024 Jan; 13(3):. PubMed ID: 38334639 [TBL] [Abstract][Full Text] [Related]
28. Mitochondria in amyotrophic lateral sclerosis: a trigger and a target. Dupuis L; Gonzalez de Aguilar JL; Oudart H; de Tapia M; Barbeito L; Loeffler JP Neurodegener Dis; 2004; 1(6):245-54. PubMed ID: 16908975 [TBL] [Abstract][Full Text] [Related]
29. Mutant SOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamics abnormalities. Magrané J; Hervias I; Henning MS; Damiano M; Kawamata H; Manfredi G Hum Mol Genet; 2009 Dec; 18(23):4552-64. PubMed ID: 19779023 [TBL] [Abstract][Full Text] [Related]
30. Defective mitochondrial dynamics is an early event in skeletal muscle of an amyotrophic lateral sclerosis mouse model. Luo G; Yi J; Ma C; Xiao Y; Yi F; Yu T; Zhou J PLoS One; 2013; 8(12):e82112. PubMed ID: 24324755 [TBL] [Abstract][Full Text] [Related]
31. The role of insulin-like growth factor 1 in ALS cell and mouse models: A mitochondrial protector. Wen D; Cui C; Duan W; Wang W; Wang Y; Liu Y; Li Z; Li C Brain Res Bull; 2019 Jan; 144():1-13. PubMed ID: 30414993 [TBL] [Abstract][Full Text] [Related]
32. Increased mitochondrial antioxidative activity or decreased oxygen free radical propagation prevent mutant SOD1-mediated motor neuron cell death and increase amyotrophic lateral sclerosis-like transgenic mouse survival. Liu R; Li B; Flanagan SW; Oberley LW; Gozal D; Qiu M J Neurochem; 2002 Feb; 80(3):488-500. PubMed ID: 11905995 [TBL] [Abstract][Full Text] [Related]
33. Decreased Mitochondrial Function, Biogenesis, and Degradation in Peripheral Blood Mononuclear Cells from Amyotrophic Lateral Sclerosis Patients as a Potential Tool for Biomarker Research. Araujo BG; Souza E Silva LF; de Barros Torresi JL; Siena A; Valerio BCO; Brito MD; Rosenstock TR Mol Neurobiol; 2020 Dec; 57(12):5084-5102. PubMed ID: 32840822 [TBL] [Abstract][Full Text] [Related]
34. Calcium dysregulation, mitochondrial pathology and protein aggregation in a culture model of amyotrophic lateral sclerosis: mechanistic relationship and differential sensitivity to intervention. Tradewell ML; Cooper LA; Minotti S; Durham HD Neurobiol Dis; 2011 Jun; 42(3):265-75. PubMed ID: 21296666 [TBL] [Abstract][Full Text] [Related]
35. New links between SOD1 and metabolic dysfunction from a yeast model of amyotrophic lateral sclerosis. Bastow EL; Peswani AR; Tarrant DS; Pentland DR; Chen X; Morgan A; Staniforth GL; Tullet JM; Rowe ML; Howard MJ; Tuite MF; Gourlay CW J Cell Sci; 2016 Nov; 129(21):4118-4129. PubMed ID: 27656112 [TBL] [Abstract][Full Text] [Related]
36. Mitochondrial dysfunction and traffic jams in amyotrophic lateral sclerosis. Jhanji R; Behl T; Sehgal A; Bungau S Mitochondrion; 2021 May; 58():102-110. PubMed ID: 33639271 [TBL] [Abstract][Full Text] [Related]
37. Misfolded SOD1 Accumulation and Mitochondrial Association Contribute to the Selective Vulnerability of Motor Neurons in Familial ALS: Correlation to Human Disease. Abu-Hamad S; Kahn J; Leyton-Jaimes MF; Rosenblatt J; Israelson A ACS Chem Neurosci; 2017 Oct; 8(10):2225-2234. PubMed ID: 28715630 [TBL] [Abstract][Full Text] [Related]
38. Single-cell RNA-seq analysis of the brainstem of mutant SOD1 mice reveals perturbed cell types and pathways of amyotrophic lateral sclerosis. Liu W; Venugopal S; Majid S; Ahn IS; Diamante G; Hong J; Yang X; Chandler SH Neurobiol Dis; 2020 Jul; 141():104877. PubMed ID: 32360664 [TBL] [Abstract][Full Text] [Related]
39. IN VITRO AND IN VIVO MODELS OF AMYOTROPHIC LATERAL SCLEROSIS: AN UPDATED OVERVIEW. Gois AM; Mendonça DMF; Freire MAM; Santos JR Brain Res Bull; 2020 Jun; 159():32-43. PubMed ID: 32247802 [TBL] [Abstract][Full Text] [Related]